Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation-论文-万方医学网

Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation

导出原文传递

翻译打印收藏纠错

作者： Schliemann, Christoph ^[1] ; Kessler, Torsten ^[2] ; Berdel, Andrew F. ^[3] ; Hemmerle, Teresa ^[4] ; Angenendt, Linus ; Altvater, Bianca ; Rossig, Claudia ; Mikesch, Jan-Henrik ; Lenz, Georg ; Schaefers, Michael ; Neri, Dario ; Stelljes, Matthias ; Berdel, Wolfgang E.

作者单位： Univ Hosp Muenster, Dept Med A, Haematol, Oncol, Munster, Germany ^[1] Philogen SpA, Siena, Italy ^[2] Univ Children Hosp Muenster, Dept Paediat Oncol & Haematol, Munster, Germany ^[3] Univ Hosp Muenster, Dept Nucl Med, Munster, Germany ^[4]

发布时间 2021-05-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除